Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
Efficacy and acceptability of lurasidone for bipolar depression: a systematic review and dose–response meta-analysis — Yu‐Wei Lin (2024) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Efficacy and acceptability of lurasidone for bipolar depression: a systematic review and dose–response meta-analysis
Shared by
Eduard Vieta
Efficacy and acceptability of lurasidone for bipolar depression: a systematic review and dose–response meta-analysis
Article
2024
en
Authors
+9 more
YL
Yu‐Wei Lin
YC
Yang‐Chieh Brian Chen
KH
Kuo‐Chuan Hung
Abstract
1 min read
INPLASY202430069.
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2024
Dose-response association of lurasidone in the treatment of bipolar depression: a systematic review and meta-analysis
Yu‐Wei Lin
,
Chih‐Sung Liang
,
Ping‐Tao Tseng
,
Kuo‐Chuan Hung
,
André F. Carvalho
,
Eduard Vieta
,
Edward Chia‐Cheng Lai
,
Pao‐Yen Lin
,
Yang‐Chieh Brian Chen
,
Chih‐Wei Hsu
,
Yu‐Kang Tu
Article
2023
Comparative efficacy and tolerability of pharmacological interventions for acute bipolar depression in adults: a systematic review and network meta-analysis
Ayşegül Yıldız
,
Spyridon Siafis
,
Dimitris Mavridis
,
Eduard Vieta
,
Stefan Leucht
Article
2009
Valproate for the treatment of acute bipolar depression: Systematic review and meta-analysis
L. A. Smith
,
Victoria Cornelius
,
J.-M. Azorin
,
Giulio Perugi
,
Eduard Vieta
,
Allan H. Young
,
Charles L. Bowden
Article
2017
Efficacy and safety of ketamine in bipolar depression: A systematic review
Susana Alberich
,
Mónica Martínez‐Cengotitabengoa
,
Purificación López‐Mahía
,
Eric P. Zorrilla
,
Nuria Núñez
,
Eduard Vieta
,
Ana González‐Pinto
Article
2009
P.2.e.026 Valproate for acute bipolar depression: systematic review and meta-analysis
Atlisa Young
,
Azorin Jm
,
Giulio Perugi
,
Eduard Vieta
,
C.L. Bowden
,
Victoria Cornelius
,
LM Smith
Discussion(0)
No comments yet. Be the first to comment.